Indirect costs of breast cancer in Lithuania in 2008

Polish Annals of Medicine

Volumn 17, Issue 1, 2010, Pages 25-35

  Ivanauskiene, Rugile ^a   Padaiga, Žilvinas ^a   Vanagas, Giedrius ^a   Juozaityte, Elona ^b  

^a KAUNAS UNIVERSITY OF MEDICINE   (Lithuania)

^b KAUNAS UNIVERSITY OF MEDICINE HOSPITAL   (Lithuania)

Author keywords

Breast canceer; Cost of illnes study; Morbidity costs; Mortality costs

Indexed keywords

ABSENTEEISM; ADULT; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER SURVIVOR; FEMALE; HEALTH CARE COST; HUMAN; LITHUANIA; MAJOR CLINICAL STUDY; MEDICAL LEAVE; MORBIDITY; PRIORITY JOURNAL; PRODUCTIVITY; SOCIAL INSURANCE;

EID: 84869461372     PISSN: 12308013     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1230-8013(10)70003-5     Document Type: Article

References (19)

1. Barron J. J., Quimbo R., Nikam P. T., Amonkar M. M.: Assessing the economic burden of breast cancer in a US managed care population. Breast Cancer Res. Treat, 2008; 109 (2): 367-377. (Pubitemid 351644849)
2. Broekx S., Hond E. D., Torfs R., Remacle A., Mertens R., D'Hooghe T., Neven P., Christiaens M. R., Simoens S.: The costs of breast cancer prior to and following diagnosis. Eur. J. Health Econ., 2010.
3. Chirikos T. N.: Economic impact of the growing population of breast cancer survivors. Cancer Control, 2001; 8 (2): 177-183. (Pubitemid 32319376)
4. Damm O., Hodek J. M., Greiner W.: Methodological standards for cost-of-illness studies using breast cancer, prostate cancer and colon cancer as an example. [Article in German]. Z. Evid. Fortbild. Qual Gesundhwes, 2009; 103 (6): 305-316.
5. Gordon L., Scuffham P., Hayes S., Newman B.: Exploring the economic impact of breast cancers during the 18 months following diagnosis. Psychooncology, 2007; 16 (12): 1130-1139. (Pubitemid 350302535)
6. Hodgson T. A., Meiners M. R.: Cost-of-illness methodology: A guide to current practices and procedures. Milbank Mem. Fund Q. Health Soc., 1982; 60 (3): 429-462.
7. Henderson J. W.: Health Economics and Policy. Cengage Learning, [Mason] 2008; 111-113.
8. Juozaitytė E., Juodžbalienė E. B., Boguš evičius A.: Kruties vė zys [Breast cancer]. Vaistu̧ žinios, Vilnius 2004.
9. Lidgren M., Wilking N., Jonsson B.: Cost of breast cancer in Sweden in 2002. Eur. J. Health Econ., 2007; 8 (1): 5-15. (Pubitemid 46295336)
10. Lidgren M., Wilking N., Jonsson B., Rehnberg C.: Resource use and costs associated with different states of breast cancer. Int. J. Technol. Assess Health Care, 2007; 23 (2): 223-231. (Pubitemid 46642729)
11. Lithuanian Cancer Registry [online database]. Cancer Registration Department of Institute of Oncology, Vilnius University, [last update: 18 January 2008]. Available at: http://www.vuoi.lt/.
12. Max W., Sung H. Y., Stark B.: The economic burden of breast cancer in California. Breast Cancer Res. Treat, 2009; 116 (1): 201-207.
13. Noyes K., Holloway R. G.: Evidence from cost-effectiveness research. Neuro Rx., 2004; 1 (3): 348-355. (Pubitemid 46591887)
14. Oliva J., Lobo F., Lopez-Bastida J., Zozaya N., Romay R.: Indirect costs of cervical and breast cancers in Spain. Eur. J. Health Econ., 2005; 6 (4): 309-313. (Pubitemid 41779929)
15. Padaiga Ž., Kurtinaitis J., Gaižauskienė A., Vanagas G., Logminienė Ž., Ivanaūskienė R., Kregždytė R., Garbuvienė M.: Krūties vėžio ekonominis vertinimas Lietuvoje [Economic evaluation of breast cancer in Lithuania]. Versus Aureus, Vilnius 2008; 23-24.
16. Radice D., Redaelli A.: Breast cancer management: quality-of-life and cost considerations. Pharmac-oeconomics, 2003; 21 (6): 383-396. (Pubitemid 36461402)
17. Remák E., Brazil L.: Cost of managing women presenting with stage IV breast cancer in the United Kingdom. Br. J. Cancer, 2004; 91: 77-83. (Pubitemid 39013048)
18. Tyczynski J. E., Plesko I., Aareleid T., Primic-Zakelj M., Dalmas M., Kurtinaitis J., Stengrevics A., Parkin D. M.: Breast cancer mortality patterns and time trends in 10 new EU member states: mortality declining in young women, but still increasing in the elderly. Int. J. Cancer, 2004; 112 (6): 1056-1064. (Pubitemid 39507014)
19. Will B. P., Berthelot J. M., Le Petit C., Tomiak E. M., Verma S., Evans W. K.: Estimates of the lifetime costs of breast cancer treatment in Canada. Eur. J. Cancer, 2000; 36 (6): 724-735. (Pubitemid 30179743)